Illumina Inc

1
WBO:ILMN (USA)   Ordinary Shares
€ 117.78 (+0.62%) Mar 18
At Loss
P/B:
3.56
Market Cap:
€ 19.00B ($ 20.66B)
Enterprise V:
€ 20.11B ($ 21.86B)
Volume:
-
Avg Vol (2M):
11.00
Also Trade In:

Business Description

Illumina Inc
NAICS : 621511 SIC : 8071
ISIN : US4523271090

Share Class Description:

WBO:ILMN: Ordinary Shares
Description
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Name Current Vs Industry Vs History
Cash-To-Debt 0.47
Equity-to-Asset 0.57
Debt-to-Equity 0.39
Debt-to-EBITDA -3.72
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 3.02
Distress
Grey
Safe
Beneish M-Score -2.73
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 24.52
9-Day RSI 30.36
14-Day RSI 35.68
6-1 Month Momentum % -0.59
12-1 Month Momentum % -36.34

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.66
Quick Ratio 1.29
Cash Ratio 0.67
Days Inventory 123.38
Days Sales Outstanding 56.74
Days Payable 52.46

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -2.9
Shareholder Yield % 0.51

Financials (Next Earnings Date:2024-04-25 Est.)

WBO:ILMN's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Illumina Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 4,178.083
EPS (TTM) (€) -6.834
Beta 0.48
Volatility % 54.11
14-Day RSI 35.68
14-Day ATR (€) 2.247309
20-Day SMA (€) 124.916
12-1 Month Momentum % -36.34
52-Week Range (€) 86.09 - 215.4
Shares Outstanding (Mil) 158.9

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Illumina Inc Filings

Filing Date Document Date Form
No Filing Data

Illumina Inc Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

Illumina Inc Frequently Asked Questions

What is Illumina Inc(WBO:ILMN)'s stock price today?
The current price of WBO:ILMN is €117.78. The 52 week high of WBO:ILMN is €215.40 and 52 week low is €86.09.
When is next earnings date of Illumina Inc(WBO:ILMN)?
The next earnings date of Illumina Inc(WBO:ILMN) is 2024-04-25 Est..
Does Illumina Inc(WBO:ILMN) pay dividends? If so, how much?
Illumina Inc(WBO:ILMN) does not pay dividend.

Press Release

Subject Date
No Press Release